ArticleIEEE transactions on medical imaging2025
Revealing Cortical Spreading Pathway of Neuropathological Events by Neural Optimal Mass Transport.
Article in IEEE transactions on medical imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- AI-enabled multimodal neuroimaging for neurotransmitter mapping in normal aging and age-related disease.Frontiers in aging neuroscience · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Positron Emission Tomography (PET) is essential for understanding the pathophysiological mechanisms underlying neurodegenerative diseases like Alzheimer's disease (AD). However, existing approaches primarily focus on stereotypical patterns of pathology burden, lacking the ability to elucidate the underlying propagation mechanisms by which pathologies spread throughout the brain over time. Given that many neurodegenerative diseases exhibit prion-like pathology spread, it is essential to uncover the spot-to-spot flow field between consecutive PET snapshots. To address this, we reformulate the problem of identifying latent cortical propagation pathways of neuropathological burden within the well-established framework of optimal mass transport (OMT). In this formulation, the dynamic spreading of pathology across longitudinal PET scans is inherently constrained by the geometry of the brain cortex. To solve this problem, we introduce a variational framework that characterizes the dynamical system of pathology propagation in the brain, ultimately reducing to a Wasserstein geodesic between two density distributions of pathology accumulation. Furthermore, we hypothesize that a well-characterized mechanism of pathology propagation will enable the prediction of future pathology accumulation at the individual level, paving the way for personalized disease progression modeling. Building on the principles of physics-informed deep models, we derive the governing equation of the underlying OMT model and introduce an explainable, generative adversarial network-inspired framework. Our approach (1) parameterizes population-level OMT dynamics through a flow adjuster and (2) predicts the spreading flow in unseen subjects using a trained flow driver. We validate the accuracy of our model on publicly available datasets, demonstrating its effectiveness in forecasting future pathology accumulation. Since our deep model adheres to the second law of thermodynamics, we further explore the propagation dynamics of tau aggregates throughout the progression of AD. In contrast to traditional methods, our physics-informed approach enhances both accuracy and interpretability, demonstrating its potential to reveal novel neurobiological mechanisms driving disease progression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.